A donna of 34 years is hospitalized inthe San Martino Polyclinic of Genoa after strong warning headache. Upon arriving in Emergency room, as reported by the Liguria Region, a low level of platelets in the blood and was subjected to fibrinolisi of some thrombi present in the part venous of hepatic circulation. The woman, originally from Savona, she was vaccinated last May 27 with the first dose of Astrazeneca.
According to reports from the specialists of the Polyclinic, the patient is “conscious and perfectly cooperative”. In the immediacy of recovery, the hospital, reported that the 34-year-old “does not show up symptomatology associated with thrombosis “. Then, like the hospital itself, however, she reported on the therapy she was subjected to. Currently the patient is hospitalized in intensive care in spontaneous breathing. The woman is in anticoagulant therapy and will be submitted to angiographic investigations precautionary measures of cerebral circulation. Given the low blood level of platelets in the blood, the Genoese hospital deemed it necessary to monitor it in intensive.
That of the Savona area is the second suspected case after the 18 year old operated for the reduction of cranial pressure linked to haemorrhage following a thrombosis, which occurred a few days after participating in a open day by Astrazeneca il May 25. Its conditions always remain “Very serious” ma “Stable”. His case had rekindled the controversy, even within the scientific community, regarding the administration of the Anglo-Swedish compound to young people, given that theAifa recommended it for over 60.
In the past few hours, Franco Locatelli, coordinator of the CTS and president of the Superior Health Council, also expressed himself: “In these hours there is asupreme attention to grasp all the signals that can alert you to any side effects that lead to consider gods indication changes – he explained – The AstraZeneca vaccine is already preferentially recommended for people over 60 years of age ”. There reflectionadded Locatelli, it must be done “also in the light of the changed epidemiological context”.